Results of Photopatch Testing in Israel: A Retrospective Cohort Study.

IF 3.2
Daniel Hilewitz, Akiva Trattner, Stav Endelman, Michal Solomon, Guy Zvi Katzir Kutzinogi, Assi Levi, Shiri Daniel Mimouni, Igor Snast
{"title":"Results of Photopatch Testing in Israel: A Retrospective Cohort Study.","authors":"Daniel Hilewitz, Akiva Trattner, Stav Endelman, Michal Solomon, Guy Zvi Katzir Kutzinogi, Assi Levi, Shiri Daniel Mimouni, Igor Snast","doi":"10.1177/17103568251378517","DOIUrl":null,"url":null,"abstract":"<p><p><u><b><i></i></b></u> <u><b><i>Background:</i></b></u> There are limited data regarding photopatch testing (PPT) in Israel. <u><b><i>Objectives:</i></b></u> To investigate the prevalence of positive reactions and concurrent diagnosis of patients that underwent PPT in a single center in Israel. <u><b><i>Methods:</i></b></u> Retrospective cohort study that included all patients that were suspected of having contact dermatitis and underwent patch testing with the European baseline series (EBS) and additionally were selectively PPT with the Scandinavian/European baseline photopatch series in a tertiary medical center in Israel (2009-2023). <u><b><i>Results:</i></b></u> Of 5234 consecutive patients tested with the EBS, 78 (1.5%) underwent PPT. Overall, 23 (29.49%) patients demonstrated positive PPT results, and 13 (56.52%; 17 positive reactions, 12 different allergens) exhibited clinically relevant reaction and were diagnosed with photoallergic contact dermatitis (PACD). Sunscreen-related allergens represented the most common relevant photoallergens (6 patients, 46.15%), with benzophenone-3 yielding positive and relevant results in 5 cases. The duration of symptoms was significantly (<i>P</i> < 0.05) longer among 13 patients with relevant PPT reaction that were diagnosed with PACD (12.16 ± 12.44 years) compared with patients with irrelevant (4.86 ± 6.75 years) or negative results (5.29 ± 7.98 years). The most common final diagnosis was allergic contact dermatitis (ACD) (21 cases, 26.92%), followed by PACD (13 cases, 16.66%), nonspecific dermatitis (5 cases, 6.41%), or atopic dermatitis (4 cases, 5.13%). About half (48.71%) of patients had indeterminate or other diagnoses, including rosacea, solar urticaria, polymorphic light eruption, and collagen vascular disease. <u><b><i>Conclusion:</i></b></u> In this retrospective Israeli study, the prevalence of positive PPT was relatively high (29%); however, falls within the wide range of reported values. Sunscreen-related allergens, specifically benzophenone-3, were the most common culprit. Among PACD patients, time-to-diagnosis was significantly delayed compared to other patients. Although the final diagnosis was heterogenous, ACD was the most common type.</p>","PeriodicalId":93974,"journal":{"name":"Dermatitis : contact, atopic, occupational, drug","volume":" ","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2025-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatitis : contact, atopic, occupational, drug","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/17103568251378517","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: There are limited data regarding photopatch testing (PPT) in Israel. Objectives: To investigate the prevalence of positive reactions and concurrent diagnosis of patients that underwent PPT in a single center in Israel. Methods: Retrospective cohort study that included all patients that were suspected of having contact dermatitis and underwent patch testing with the European baseline series (EBS) and additionally were selectively PPT with the Scandinavian/European baseline photopatch series in a tertiary medical center in Israel (2009-2023). Results: Of 5234 consecutive patients tested with the EBS, 78 (1.5%) underwent PPT. Overall, 23 (29.49%) patients demonstrated positive PPT results, and 13 (56.52%; 17 positive reactions, 12 different allergens) exhibited clinically relevant reaction and were diagnosed with photoallergic contact dermatitis (PACD). Sunscreen-related allergens represented the most common relevant photoallergens (6 patients, 46.15%), with benzophenone-3 yielding positive and relevant results in 5 cases. The duration of symptoms was significantly (P < 0.05) longer among 13 patients with relevant PPT reaction that were diagnosed with PACD (12.16 ± 12.44 years) compared with patients with irrelevant (4.86 ± 6.75 years) or negative results (5.29 ± 7.98 years). The most common final diagnosis was allergic contact dermatitis (ACD) (21 cases, 26.92%), followed by PACD (13 cases, 16.66%), nonspecific dermatitis (5 cases, 6.41%), or atopic dermatitis (4 cases, 5.13%). About half (48.71%) of patients had indeterminate or other diagnoses, including rosacea, solar urticaria, polymorphic light eruption, and collagen vascular disease. Conclusion: In this retrospective Israeli study, the prevalence of positive PPT was relatively high (29%); however, falls within the wide range of reported values. Sunscreen-related allergens, specifically benzophenone-3, were the most common culprit. Among PACD patients, time-to-diagnosis was significantly delayed compared to other patients. Although the final diagnosis was heterogenous, ACD was the most common type.

以色列光贴片检测结果:一项回顾性队列研究。
背景:以色列关于光贴测试(PPT)的数据有限。目的:调查以色列单一中心接受PPT治疗的患者的阳性反应和并发诊断的发生率。方法:回顾性队列研究纳入了所有怀疑患有接触性皮炎的患者,并在2009-2023年在以色列的一家三级医疗中心接受了欧洲基线系列(EBS)的贴片测试,并选择性地使用斯堪的纳维亚/欧洲基线光贴片系列进行PPT测试。结果:5234例连续EBS患者中,78例(1.5%)接受了PPT。总体而言,PPT阳性23例(29.49%),阳性反应13例(56.52%),17例阳性反应,12种不同的过敏原,有临床相关反应,诊断为光过敏性接触性皮炎(PACD)。防晒霜相关过敏原是最常见的相关光过敏原(6例,46.15%),二苯甲酮-3阳性相关5例。13例有相关PPT反应诊断为PACD患者的症状持续时间(12.16±12.44年)明显长于无相关PPT反应患者(4.86±6.75年)或阴性患者(5.29±7.98年)(P < 0.05)。最常见的最终诊断是过敏性接触性皮炎(ACD)(21例,26.92%),其次是PACD(13例,16.66%)、非特异性皮炎(5例,6.41%)和特应性皮炎(4例,5.13%)。约一半(48.71%)的患者有不确定或其他诊断,包括酒渣鼻、日光性荨麻疹、多形性光疹和胶原血管病。结论:在以色列的回顾性研究中,PPT阳性的患病率相对较高(29%);然而,它落在报告值的广泛范围内。与防晒霜有关的过敏原,特别是二苯甲酮-3,是最常见的罪魁祸首。与其他患者相比,PACD患者的诊断时间明显延迟。虽然最终的诊断是不一致的,但ACD是最常见的类型。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信